With new technology and treatments rapidly emerging, is it legal for a health insurance company to deny coverage to insured patients for certain treatments for cancer?
Should cost be a factor in denying coverage for "experimental" cancer treatments that may prolong a patient's life?
Often the difference between life and death for cancer patients depends on the type of treatment and services their health insurance carrier will cover. Currently, some of the most innovative treatments are denied or routinely labeled as "experimental" by many insurance companies.
Cancer patients are sometimes unaware of the options available to appeal decisions such as these. Others may not have the financial ability to do so. Unfortunately, women in these circumstances may seek expert advice only after it is too late, due to the timing of treatment or after they have exhausted the appeals that a knowledgeable advocate might have been able to pursue successfully.
Delaying treatment for cancer can seriously affect a woman's chance of survival. In combating this disease, women and their families must be proactive. They should consider the avenues available to them that may help them receive the appropriate health care treatment and services prescribed by their treating physicians. It is their legal right!